Analysis of clinical characteristics, diagnosis and treatment status of hospitalized patients with chronic heart failure in Xinjiang,China

Abstract

Abstract Purpose To investigate and analyze the demographic data, clinical characteristics, treatment and prognosis of hospitalized patients with chronic heart failure (CHF) in Xinjiang. Methods The data included in this study are the subgroup data from the Xinjiang of the China Heart Failure Center Registration Study. From January 1, 2018 to September 1, 2020, 7677 CHF patients who meet the CHF diagnostic criteria and have complete clinical data will be treated as the research objects. Collect selected demographic data, heart failure risk factors, heart failure etiology, laboratory and examination results, medication use and prognosis information. Results (1)The causes of CHF are: coronary atherosclerotic heart disease (65.57%), dilated cardiomyopathy (11.05%), hypertension (9.01%) and valvular heart disease (8.7%).༈2༉A total of 78 CHF patients (1.00%) died in the hospital during hospitalization. A total of 512 CHF deaths (6.8%) occurred within 12 months of discharge.༈3༉HFpEF patients are older, the proportion of women is the highest, and the proportion of patients with CHF comorbidities is the highest (P < 0.05).༈4༉Although there was no significant difference in the standardized medications of CHF in the provincial and municipal tertiary hospitals, the proportion of pacing intervention and coronary revascularization in the provincial tertiary hospitals was higher than that in the municipal tertiary hospitals (P < 0.05). Conclusion The main cause of CHF in Xinjiang is coronary heart disease, and patients with different types of CHF have different clinical characteristics. The mortality rate of CHF inside and outside the hospital is still high, and there is a certain gap between the treatment practice of CHF in Xinjiang and the treatment recommended by the guidelines. It is necessary to establish and improve a standardized, individualized, and standardized diagnosis and treatment system for CHF in Xinjiang.